JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 153 filers reported holding JUNO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 2.17 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $597,000 | -22.4% | 31,662 | +23.5% | 0.00% | 0.0% |
| Q3 2016 | $769,000 | -21.0% | 25,635 | +1.3% | 0.00% | 0.0% |
| Q2 2016 | $973,000 | +446.6% | 25,315 | +440.3% | 0.00% | – |
| Q1 2016 | $178,000 | -33.3% | 4,685 | -22.9% | 0.00% | – |
| Q4 2015 | $267,000 | +11.7% | 6,076 | +3.3% | 0.00% | – |
| Q3 2015 | $239,000 | -32.5% | 5,883 | -11.3% | 0.00% | – |
| Q2 2015 | $354,000 | +91.4% | 6,630 | +117.6% | 0.00% | – |
| Q1 2015 | $185,000 | -59.3% | 3,047 | -65.0% | 0.00% | -100.0% |
| Q4 2014 | $454,000 | – | 8,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |